Novartis enters agreement to acquire Mariana Oncology, …

May 2, 2024 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and …

CouponFollow Extension

$1
OFF

Novartis Buys Mariana Oncology In $1B Acquisition, Bolsters …

6 days from now

May 2, 2024 · Novartis pushed deeper into radioligand therapy Thursday, announcing a $1 billion buyout that will give it control of Mariana Oncology ’s preclinical cancer pipeline and clinical …

biospace.com

$1
OFF

Novartis Deepens Radiopharma Presence With $1B Mariana …

6 days from now

Jun 26, 2024 · In a strategic move, Novartis has secured a $1 billion upfront acquisition of Mariana Oncology, a company established in 2021 with funding from Atlas Venture, Access …

patsnap.com

$1
OFF

Novartis Extends Its Reach In Radiopharmaceuticals With $1B …

6 days from now

May 2, 2024 · Novartis’s two commercialized radiopharmaceuticals are from acquisitions: Lutathera came in 2017 followed by Pluvicto in 2018. The Swiss pharma giant’s purchase of …

medcitynews.com

$1
OFF

Novartis Buys Radiopharma Firm Mariana Oncology For $1 Billion

6 days from now

May 16, 2024 · Novartis is the latest drug company to buy up a radiopharmaceutical-focused biotech firm with its planned purchase of Mariana Oncology for $1 billion. …

acs.org

$1
OFF

Novartis To Buy Mariana Oncology In Radiopharmaceutical Expansion

6 days from now

May 2, 2024 · Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it has agreed to pay $1 billion to acquire biotechnology company Mariana Oncology. …

biopharmadive.com

$1.75
OFF

Novartis To Acquire Radiopharmaceutical Firm Mariana Oncology …

6 days from now

May 3, 2024 · Novartis on Thursday announced plans to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75 billion. The Swiss drugmaker said the deal will bolster its …

radiologybusiness.com

$1.75
OFF

Novartis To Acquire Mariana For Up To $1.75B, Expanding …

6 days from now

May 2, 2024 · Novartis has agreed to acquire Mariana Oncology for up to $1.75 billion, the companies said today, in a deal that would further expand the buyer’s radiopharmaceutical …

genengnews.com

$1
OFF

Novartis To Buy Mariana Oncology, Paying $1 Billion Upfront (1)

6 days from now

May 2, 2024 · Novartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can specifically target cancer cells.. The Swiss company said Thursday it will pay …

bloomberglaw.com

$1
OFF

Novartis To Buy Mariana Oncology For $1B Upfront - MSN

6 days from now

Novartis (NYSE:NVS) has agreed to acquire cancer drugmaker Mariana Oncology for an upfront payment of $1B and an additional $750M in milestone payments. The transaction, subject to …

msn.com

$1
OFF

Novartis Makes A $1B Radiopharma Deal, Buying Mariana Oncology

6 days from now

May 2, 2024 · Novartis will pay $1 billion upfront to acquire radiopharmaceutical startup Mariana Oncology, just eight months after the preclinical biotech company disclosed a $175 million …

endpts.com

FAQs about Novartis enters agreement to acquire Mariana Oncology, … Coupon?

Will Novartis buy Mariana oncology?

With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown with Mariana Oncology in a $1 billion upfront acquisition. ...

Is Novartis a top player in the radiopharmaceutical space?

Novartis is firming its role as the top player in the radiopharmaceutical space with the acquisition of Mariana Oncology for $1bn upfront, and up to $750m in additional milestone-based payments. Novartis will acquire Mariana’s lead candidate MC-339, a radioligand therapy (RLT) designed to target small-cell lung cancer. ...

What is Mariana & Novartis' strategy for end-to-end radiopharmaceutical R&D?

“Our strategy has centered on overcoming the unique challenges of end-to-end radiopharmaceutical R&D and ultimately, delivery of these drugs to the bedside,” Simon Read, PhD, Mariana’s founder and CEO, said in a statement. “Both Mariana and Novartis are committed to transforming cancer care, and together we will be in a better position to do that.” ...

How much will Novartis pay Mariana shareholders?

According to the deal terms announced Thursday, Novartis is paying $1 billion up front. Milestone payments could bring the Mariana shareholders another $750 million. Novartis is already a leader in radiopharmaceuticals with two commercialized therapies, Lutathera for gastroenteropancreatic neuroendocrine tumors and Pluvicto for prostate cancer. ...

Is Mariana a high-value radiopharmaceutical company?

Last year, Mariana had raised $175m in a Series B round from several funds and pharma giant Eli Lilly. This marks the second high-value deal in the radiopharmaceutical space in the last few months, with pharma company AstraZeneca acquiring radio-conjugate biotech Fusion for $2.4bn in March, gaining lead agent FPI-2265 in the process. ...

Which pharmaceuticals did Novartis buy?

Novartis’s two commercialized radiopharmaceuticals are from acquisitions: Lutathera came in 2017 followed by Pluvicto in 2018. The Swiss pharma giant’s purchase of Mariana continues a newer streak of radiopharmaceuticals dealmaking by other big pharma layers. ...